Monitoring method, central station and central monitoring system

Abstract

The present application relates to the technical field of medical equipment, in particular to a monitoring method, a central station and a central monitoring system, the monitoring method comprising: acquiring physiological parameter data and infusion data of at least one target object at the same time; displaying the physiological parameter data and the infusion data in a corresponding parameter display area in a monitoring main interface to jointly analyze the vital sign changes of the target object, the monitoring main interface comprising a plurality of parameter display areas, each parameter display area corresponding to each target object; receiving adjustment settings of the infusion data after joint analysis by an operating object, and displaying the infusion data after adjustment settings in the parameter display area. The monitoring method jointly observes the physiological parameter data and the infusion data, which facilitates medical staff to understand the vital sign conditions and infusion system conditions of the target object, and improves the monitoring efficiency.

Description

TECHNICAL FIELD

[0001] The present application relates to the technical field of medical equipment, in particular to a monitoring method, a central station and a central monitoring system. BACKGROUND

[0002] At present, as a device capable of displaying and managing infusion information, an infusion system has important significance for clinical application. Generally, an infusion system only focuses on the information of an infusion device currently in use, such as displaying real-time infusion progress and providing display of alarm information. As a remote monitoring device for a bedside infusion device, such a method can indeed greatly improve medical care efficiency. Meanwhile, an infusion system can help nurses to quickly locate patients in need of care.

[0003] However, in the monitoring process, medical staff not only need to master the information of an infusion device, but also need to know the information of a physiological parameter monitoring device, so as to timely monitor target objects. However, for medical staff, the current infusion system needs to learn too many types of operation systems, and in the actual use process, it does not reasonably and efficiently improve the work efficiency of medical staff, resulting in low monitoring efficiency. SUMMARY

[0004] Therefore, the embodiments of the present application provide a monitoring method, a central station and a central monitoring system to solve the problem of low monitoring efficiency caused by the existing monitoring method.

[0005] According to a first aspect, the embodiments of the present application provide a monitoring method, comprising:

[0006] acquiring physiological parameter data and infusion data of at least one target object at the same time;

[0007] displaying the physiological parameter data and the infusion data in a corresponding parameter display area in a monitoring main interface to jointly analyze the vital sign changes of the target object, wherein the monitoring main interface comprises a plurality of parameter display areas, and each parameter display area corresponds to each target object;

[0008] receiving adjustment settings of the infusion data after joint analysis by an operation object, and displaying the infusion data after adjustment settings in the parameter display area.

[0009] The monitoring method provided in the embodiments of the present application displays physiological parameter data and infusion data on the same monitoring main interface, that is, the physiological parameter data and the infusion data are jointly observed to jointly analyze the vital sign changes of the target object, and then the infusion data is adjusted and set after the joint analysis, and the adjusted and set infusion data is displayed on the parameter display area, so that the medical staff can understand the vital sign condition and the infusion system condition of the target object, the medical staff can obtain corresponding information, and the monitoring efficiency is improved.

[0010] With reference to the first aspect, in a first implementation manner of the first aspect, the monitoring main interface further includes a waveform display area, each waveform display area corresponds to each parameter display area, and the method further includes:

[0011] displaying a waveform of the physiological parameter data on the waveform display area.

[0012] The monitoring method provided in the embodiments of the present application displays the waveform of the physiological parameter data and the corresponding data value on the monitoring main interface, so that the medical staff can not only know the change of the physiological parameter, but also know the real-time value of each physiological parameter in time.

[0013] With reference to the first aspect or the first implementation manner of the first aspect, in a second implementation manner of the first aspect, the infusion data includes infusion remaining time and infusion alarm identifier, the parameter display area includes a remaining time display area and an alarm display area, and the displaying the physiological parameter data and the infusion data in the corresponding parameter display area in the monitoring main interface includes:

[0014] displaying the infusion remaining time in the remaining time display area of the corresponding parameter display area and displaying the infusion alarm identifier in the alarm display area of the corresponding parameter display area, the infusion alarm identifier corresponding to the infusion remaining time.

[0015] The monitoring method provided in the embodiments of the present application displays the infusion remaining time and the infusion alarm identifier, so that the medical staff can adjust and set the action and the work flow based on the infusion alarm identifier.

[0016] With reference to the first aspect, in a third implementation manner of the first aspect, the parameter display area includes an infusion display area, and the method further includes:

[0017] in response to a selection operation on the infusion display area, displaying a drug statistical analysis interface, the drug statistical analysis interface including a drug display area and a physiological parameter display area;

[0018] in response to a selection operation on the physiological parameter data and the infusion data, determining infusion data of a target drug and physiological parameter data of the target drug;

[0019] The infusion data of the target drug is displayed in the drug display area, and the target physiological parameter data is displayed in the physiological parameter display area.

[0020] The monitoring method provided in this invention performs statistical analysis on drug infusion data and target physiological parameter data in a drug statistical analysis interface, which helps medical staff understand the impact of infused drugs on the vital signs of the target subject. Subsequently, the dosage and rate of drugs can be adjusted based on the changes in vital signs caused by changes in infused drugs, which can be used to assist clinical precision nursing.

[0021] In conjunction with the third embodiment of the first aspect, in the fourth embodiment of the first aspect, the drug statistical analysis interface further includes a target selection area, and the step of determining the infusion data and target physiological parameter data of the target drug in response to the selection operation of the physiological parameter data and the infusion data includes:

[0022] In response to a selection operation on a parameter selection label in the target selection area, a parameter selection interface is displayed;

[0023] In response to the selection operation of physiological parameters in the parameter selection interface, the target physiological parameter is determined;

[0024] Based on the physiological parameter data and the target physiological parameter, the target physiological parameter data is determined.

[0025] The monitoring method provided in this invention provides parameter selection labels to facilitate medical staff in setting different physiological parameters for different target subjects, thereby enabling personalized monitoring of the target subjects.

[0026] In conjunction with the fourth embodiment of the first aspect, in the fifth embodiment of the first aspect, the parameter selection interface includes a parameter list and a parameter group list, each entry in the parameter group list includes at least two physiological parameters, and determining the target physiological parameter in response to a selection operation of physiological parameters in the parameter selection interface includes:

[0027] In response to a selection operation on the parameter list or the parameter group list, the target physiological parameter is determined.

[0028] The monitoring method provided in this embodiment of the invention provides a parameter group list. By selecting items in the parameter group list, at least two physiological parameters can be determined at once, reducing the number of times the parameter list is selected and improving monitoring efficiency.

[0029] In conjunction with the fourth embodiment of the first aspect, in the sixth embodiment of the first aspect, the step of determining the target physiological parameter in response to a selection operation of a physiological parameter in the parameter selection interface further includes:

[0030] In response to the operation of creating a parameter group for the target physiological parameters, a target parameter group is created.

[0031] The monitoring method provided in this invention provides adaptive creation of target parameter groups, which can combine physiological parameters according to the needs of medical staff, facilitating the selection of subsequent parameters.

[0032] In conjunction with the fourth embodiment of the first aspect, in the seventh embodiment of the first aspect, the step of determining the infusion data and target physiological parameter data of the target drug in response to the selection operation of the physiological parameter data and the infusion data includes:

[0033] In response to a selection operation on a drug selection label in the target selection area, a drug selection interface is displayed;

[0034] In response to a drug selection operation in the drug selection interface, the target drug is determined;

[0035] Based on the infusion data and the target drug, the infusion data for the target drug are determined.

[0036] The monitoring method provided in this invention provides personalized selection of target drugs for target subjects, configuring different target drugs for different target subjects, which facilitates monitoring by medical staff.

[0037] In conjunction with the seventh embodiment of the first aspect, in the eighth embodiment of the first aspect, determining the infusion data of the target drug based on the infusion data and the target drug includes:

[0038] In response to the selection operation of the drug curve label in the target selection area, the drug curve selection interface is displayed;

[0039] In response to the selection operation of drug attributes in the drug curve selection interface, the drug attributes of the target drug are determined, including infusion rate and cumulative infusion volume;

[0040] Based on the infusion data, the target drug, and the drug properties of the target drug, the infusion data of the target drug is determined.

[0041] According to a second aspect, embodiments of the present invention also provide a central station, comprising:

[0042] The system includes a display interface, a memory, and a processor, which are interconnected. The memory stores computer instructions, and the processor executes these computer instructions to perform the monitoring method described in the first aspect or any embodiment of the first aspect of the present invention.

[0043] The central station provided in this embodiment of the invention simultaneously displays physiological parameter data and infusion data on the same monitoring main interface. That is, it performs joint observation of physiological parameter data and infusion data to jointly analyze changes in the vital signs of the target subject. After joint analysis, the infusion data is adjusted and set, and then the adjusted infusion data is displayed in the parameter display area. This makes it convenient for medical staff to understand the vital signs and infusion system status of the target subject, enabling medical staff to obtain relevant information and improving monitoring efficiency.

[0044] According to a third aspect, embodiments of the present invention also provide a central monitoring system, comprising:

[0045] Infusion system, used to acquire infusion data of the target object;

[0046] A physiological parameter monitoring device is used to acquire physiological parameter data of the target object;

[0047] The central station described in the second aspect of the present invention is communicatively connected to the infusion system and the physiological parameter monitoring device.

[0048] The central monitoring system provided in this invention displays physiological parameter data from physiological parameter monitoring devices and infusion data from the infusion system on the same monitoring main interface of the central station. That is, the physiological parameter data and infusion data are observed together to jointly analyze the changes in vital signs of the target object, which makes it easier for medical staff to understand the vital signs and infusion system status of the target object, enabling medical staff to obtain relevant information and improving monitoring efficiency. Attached Figure Description

[0049] To more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0050] Figure 1 This is a schematic diagram of the hardware structure of a central station according to an embodiment of the present invention;

[0051] Figure 2 This is a structural block diagram of a central monitoring system provided according to an embodiment of the present invention;

[0052] Figure 3 This is a flowchart of a monitoring method according to an embodiment of the present invention;

[0053] Figure 4This is a schematic diagram of the monitoring main interface according to an embodiment of the present invention;

[0054] Figure 5 This is a flowchart of a monitoring method according to an embodiment of the present invention;

[0055] Figure 6 This is a schematic diagram of the monitoring main interface according to an embodiment of the present invention;

[0056] Figure 7 This is a flowchart of a monitoring method according to an embodiment of the present invention;

[0057] Figure 8 This is a schematic diagram of the drug statistical analysis interface according to an embodiment of the present invention;

[0058] Figure 9 This is a schematic diagram of a parameter selection interface according to an embodiment of the present invention;

[0059] Figure 10 This is a schematic diagram of a drug selection interface according to an embodiment of the present invention;

[0060] Figure 11 This is the drug curve selection interface according to an embodiment of the present invention. Detailed Implementation

[0061] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0062] The monitoring method provided in this invention combines infusion data and physiological parameter data of the target subject for joint monitoring, enabling joint analysis of changes in the target subject's vital signs and achieving real-time display of vital signs and infusion information. Simultaneously, after joint analysis, the user can adjust the infusion data, and the adjusted infusion data is displayed in real-time on the main monitoring interface. This facilitates medical staff in simultaneously monitoring the target subject's physiological parameters and infusion progress, and provides real-time access to the adjusted infusion data, avoiding the complexity of operating multiple different systems simultaneously.

[0063] Furthermore, the monitoring method also provides an analysis interface that links physiological parameters with drugs, which can provide effective evidence and clinical decision support for clinical auxiliary diagnosis, greatly promote the development of precision medicine, and reduce the treatment risk of the target subjects.

[0064] Furthermore, the monitoring method also supports personalized configurations such as visualization, which can provide different information selection options for different departments, reduce departmental workload, and improve monitoring efficiency.

[0065] This invention provides a central station connected to an infusion system and a physiological parameter monitoring device. The infusion system is used to determine the infusion data of a target object, and the physiological parameter monitoring device is used to determine the physiological parameter data of the target object. The central station acquires the infusion data and physiological parameter data from the infusion system and the physiological parameter monitoring device, respectively, and displays both types of data in the parameter display area of ​​the same monitoring main interface. Simultaneously, the central station's main display interface provides at least one parameter display area for monitoring at least one target object at the same time. Each target object has a corresponding parameter display area, and different parameter display areas contain an identification identifier for the target object to distinguish them.

[0066] This central monitoring station can be set up at the nurses' station for remote monitoring of various target subjects. The main monitoring interface of the central station can simultaneously display infusion data and physiological parameter data for multiple target subjects. For example, if the central station is monitoring 10 target subjects simultaneously, the main monitoring interface can only display the real-time data of a maximum of 4 target subjects at a time; therefore, the real-time data of the 10 target subjects needs to be displayed in pages. Of course, the maximum number of target subjects that can be displayed simultaneously on the main monitoring interface can be adjusted according to actual needs; there is no limit to this.

[0067] The central station also features human-computer interaction, allowing medical staff to personalize monitoring data for each target individual. For example, the infusion system provides multiple types of infusion data, enabling medical staff to monitor these data for each target individual based on their needs. Similarly, physiological parameter monitoring equipment provides multiple physiological parameters, allowing medical staff to monitor these parameters for each target individual and determine the target physiological parameter from among them.

[0068] The specific monitoring methods for the central station will be described in detail below.

[0069] Figure 1 This is a schematic diagram of the structure of a central station provided in an optional embodiment of the present invention, such as... Figure 1 As shown, the central station may include: at least one processor 101, such as a CPU (Central Processing Unit), at least one communication interface 103, memory 104, at least one communication bus 102, and a display interface. Figure 1(Not shown in the diagram). The communication bus 102 is used to enable communication between these components. The communication interface 103 may include a display screen and a keyboard; optionally, the communication interface 103 may also include a standard wired interface or a wireless interface. The memory 104 may be high-speed RAM (Random Access Memory) or non-volatile memory, such as at least one disk drive. Optionally, the memory 104 may also be at least one storage device located remotely from the aforementioned processor 101. The memory 104 stores application programs, and the processor 101 calls the program code stored in the memory 104 to perform the steps of any of the monitoring methods described below.

[0070] The communication bus 102 can be a peripheral component interconnect (PCI) bus or an extended industry standard architecture (EISA) bus, etc. The communication bus 102 can be divided into an address bus, a data bus, a control bus, etc. For ease of representation, Figure 1 The bus is represented by a single thick line, but this does not mean that there is only one bus or one type of bus.

[0071] The memory 104 may include volatile memory, such as random-access memory (RAM); the memory may also include non-volatile memory, such as flash memory, hard disk drive (HDD) or solid-state drive (SSD); the memory 104 may also include a combination of the above types of memory.

[0072] The processor 101 can be a central processing unit (CPU), a network processor (NP), or a combination of CPU and NP.

[0073] The processor 101 may further include a hardware chip. This hardware chip may be an application-specific integrated circuit (ASIC), a programmable logic device (PLD), or a combination thereof. The PLD may be a complex programmable logic device (CPLD), a field-programmable gate array (FPGA), a generic array logic (GAL), or any combination thereof.

[0074] Optionally, the memory 104 is also used to store program instructions. The processor 101 can invoke the program instructions to implement the monitoring method as shown in any embodiment of this application.

[0075] The central station provided in this embodiment simultaneously displays physiological parameter data and infusion data on the same monitoring main interface. That is, it performs joint observation of physiological parameter data and infusion data to jointly analyze changes in the vital signs of the target subject. Then, based on the results of the joint analysis, it adjusts settings such as the infusion rate of the infusion data and displays the adjusted infusion data in the parameter display area. This facilitates medical staff to monitor the vital signs and infusion system status of the target subject in real time, improving monitoring efficiency.

[0076] This invention also provides a central monitoring system, such as... Figure 2 As shown, the central monitoring system includes a central station 10, an infusion system 20, and physiological parameter monitoring equipment 30. A detailed description of the central station 10 is provided above and will not be repeated here.

[0077] Specifically, the infusion system 20 is used to acquire infusion data of the target object; the physiological parameter monitoring device 30 is used to acquire physiological parameter data of the target object; the central station 10 is communicatively connected to the infusion system 20 and the physiological parameter monitoring device 30, and is used to acquire infusion data and physiological parameter data of each target object.

[0078] The specific number of the central station 10, infusion system 20, and physiological parameter monitoring devices 30 included in the central monitoring system can be set according to actual needs. The number of infusion systems 20 and physiological parameter monitoring devices 30 connected to the central station 10 is also set according to actual needs, and no limitation is made here. The specific type of physiological parameter monitoring device 30 can be set according to the target object. For example, the same physiological parameter monitoring device 30 can be used to simultaneously monitor various physiological parameters of the target object, or multiple physiological parameter monitoring devices 30 can be used to monitor various physiological parameters of the same target object, and so on.

[0079] The central monitoring system provided in this embodiment simultaneously displays physiological parameter data from physiological parameter monitoring devices and infusion data from the infusion system on the same monitoring main interface of the central station. That is, it performs joint observation of physiological parameter data and infusion data to jointly analyze changes in the vital signs of the target subject. Then, based on the results of the joint analysis, it adjusts settings such as the infusion rate of the infusion data and displays the adjusted infusion data in the parameter display area. This facilitates medical staff to monitor the vital signs and infusion system status of the target subject in real time, thereby improving monitoring efficiency.

[0080] According to an embodiment of the present invention, a monitoring method embodiment is provided. It should be noted that the steps shown in the flowchart in the accompanying drawings can be executed in a computer system such as a set of computer-executable instructions. Furthermore, although a logical order is shown in the flowchart, in some cases, the steps shown or described may be executed in a different order than that shown here.

[0081] This embodiment provides a monitoring method that can be used in the aforementioned central station. Figure 3 This is a flowchart of a monitoring method according to an embodiment of the present invention, such as... Figure 3 As shown, the process includes the following steps:

[0082] S11, acquire physiological parameter data and infusion data of at least one target object at the same time.

[0083] As described above, the central station is communicatively connected to the infusion system and the physiological parameter monitoring equipment. Simultaneously, the central station acquires infusion data from the infusion system and physiological parameter data from the physiological parameter monitoring equipment for the target individual.

[0084] Specifically, the central station can collect and analyze data from the infusion system and physiological parameter monitoring equipment based on the HL7 communication protocol, providing a basis for establishing a correlation between the two. During the infusion process, medical staff will administer a specific therapeutic drug to the target subject according to the doctor's order and set the infusion rate, while simultaneously monitoring the target subject's physiological parameter data to ensure that the target subject's vital signs remain normal during the infusion process.

[0085] Physiological parameters include, but are not limited to, blood pressure, blood oxygen, heart rate, pulse rate, etc. Of course, different physiological parameters can be set according to different departments, and the specific settings can be made according to the application scenario.

[0086] The above methods for obtaining infusion data and physiological parameter data form the basis for implementing the present invention. This communication method is only one form of communication, and the scope of protection of the present invention is not limited thereto.

[0087] S12, display the physiological parameter data and infusion data in the corresponding parameter display area of ​​the monitoring main interface, so as to perform joint analysis on the changes in the vital signs of the target object.

[0088] The monitoring main interface includes multiple parameter display areas, each of which corresponds to a target object.

[0089] like Figure 4 As shown, the main monitoring interface includes multiple parameter display areas. The central station displays the acquired physiological parameter data and infusion data in the corresponding parameter display areas. It should be noted that... Figure 4 This is an example and does not limit the scope of protection of the present invention.

[0090] For example, the main monitoring interface can display real-time data from up to five target subjects simultaneously. Correspondingly, the main monitoring interface can be divided into five parameter display areas, each corresponding to a target subject. After acquiring physiological parameter data and waveform data from the same target subject, the central station displays them in the corresponding parameter display area.

[0091] Optionally, each parameter display area may include a physiological parameter display area and an infusion display area. Accordingly, the physiological parameter display area of ​​each parameter display area is used to display the physiological parameter data of the corresponding target object, and the infusion display area is used to display the infusion data of the corresponding target object. The five designated parameter display areas are labeled with the basic information of the corresponding target object, such as name, bed number, etc.

[0092] S13: After receiving the operation object and performing joint analysis, adjust the settings of the infusion data and display the adjusted infusion data in the parameter display area.

[0093] After the central monitoring station performs a joint analysis of the target subject's physiological parameter data and infusion data, the results are displayed on the main monitoring interface. Based on these results, the user can adjust the infusion data according to their needs. These adjustments include, but are not limited to, modifications made by medical staff to the original infusion data based on the physiological parameter data. For example, adjusting the dosage of the original infusion agent; adjusting the infusion rate to be higher or lower; or stopping the infusion when physiological parameters are abnormal.

[0094] The monitoring method provided in this embodiment displays physiological parameter data and infusion data simultaneously on the same monitoring main interface. That is, it performs joint observation of physiological parameter data and infusion data to jointly analyze the changes in vital signs of the target subject. After joint analysis, the infusion data is adjusted and set, and then the adjusted infusion data is displayed in the parameter display area. This makes it convenient for medical staff to understand the vital signs and infusion system status of the target subject, enabling medical staff to obtain relevant information and improving monitoring efficiency.

[0095] This embodiment provides a monitoring method that can be used in the aforementioned central station. Figure 5 This is a flowchart of a monitoring method according to an embodiment of the present invention, such as... Figure 5 As shown, the process includes the following steps:

[0096] S21, acquire physiological parameter data and infusion data of at least one target object at the same time.

[0097] Please see details Figure 3 S11 of the illustrated embodiment will not be described again here.

[0098] S22 displays physiological parameter data and infusion data in the corresponding parameter display area of ​​the monitoring main interface to perform joint analysis of changes in the vital signs of the target subject.

[0099] For physiological parameters, real-time data can be displayed as waveforms or data values. Therefore, the monitoring main interface also includes a waveform display area. For infusion data, this includes the remaining infusion time and infusion alarm indicators. The infusion alarm indicators can be distinguished by different colors, with different colors indicating different priorities. For example, as shown in Table 1:

[0100] Table 1 Infusion Alarm Symbols

[0101]

[0102] Of course, infusion alarm indicators are not limited to the color distinctions mentioned above; other methods can also be used for differentiation.

[0103] Furthermore, the parameter display area includes a remaining time display area and an alarm display area. Based on this, S22 above includes:

[0104] S221 displays the waveform of physiological parameter data in the waveform display area.

[0105] The central station represents some or all of the physiological parameter data using waveforms, and some or all of the physiological parameter data using data values. The specific selection of which physiological parameters are represented as waveforms and which as data values ​​is determined based on the actual application. Specifically, the central station displays physiological parameters intended for waveform display in the corresponding waveform display area, and physiological parameters intended for data value display in the corresponding parameter display area.

[0106] Alternatively, the same physiological parameter can be represented using both waveform representation and data value representation.

[0107] S222, display the remaining infusion time in the remaining time display area of ​​the corresponding parameter display area, and display the infusion alarm indicator in the alarm display area of ​​the corresponding parameter display area.

[0108] The infusion alarm indicator corresponds to the remaining infusion time.

[0109] As mentioned above, the remaining infusion time and infusion alarm indicators are obtained from the infusion system. The monitoring equipment displays the remaining infusion time in the remaining time display area of ​​the corresponding parameter display area, and displays the infusion alarm indicator in the alarm display area of ​​the corresponding parameter display area.

[0110] For example, Figure 6 An optional implementation of the monitoring main interface 201 is shown. Medical staff can observe real-time monitoring data for multiple different target subjects on this interface. The central station displays the acquired infusion data and physiological parameter data on this monitoring main interface. Specifically, 202 is the waveform display area, showing the real-time waveforms of the corresponding physiological parameters, such as ECG waveforms, respiratory waveforms, and blood oxygen waveforms; 203 displays target subject information, including the target subject's bed number and name, facilitating medical staff identification of the target subject requiring bedside intervention and saving search time; 206 is the data display area within the parameter display area, used to display the data values ​​of the target subject's physiological parameters, allowing medical staff to quickly locate abnormal physiological parameters; 204 is the alarm display area, used to indicate infusion alarm indicators for the target subject, marked with different colors depending on the actual status, with different colors indicating that medical staff may need to take action on different target subjects; 205 is the remaining time display area, used to assist medical staff in judging the infusion progress.

[0111] Medical staff can view real-time data from the infusion system and physiological parameter monitoring devices on the main monitoring interface 201. Alarm indicators inform medical staff of the current vital signs status of the target patient and the status of the infusion system, providing them with relevant information. Based on this, medical staff can adjust the actions and workflows accordingly. The alarm indicators are not limited to infusion alarms but also include physiological parameter alarms. For example, the central station sets normal ranges for various physiological parameters. If a target patient's physiological parameter data is outside the normal range, it will also be displayed on the main monitoring interface. For instance, if the blood pressure of patient in bed 01 is high, the blood pressure value can be displayed using color differentiation to prompt medical staff to take appropriate action. This allows medical staff to be aware of ongoing alarm information and take appropriate action on high-priority emergency alarms, improving the quality of care.

[0112] S23: After receiving the operation object and performing joint analysis, adjust the settings of the infusion data and display the adjusted infusion data in the parameter display area.

[0113] Please see details Figure 3 S13 of the illustrated embodiment will not be described again here.

[0114] The monitoring method provided in this embodiment simultaneously displays the waveform data and data values ​​of physiological parameters on the main monitoring interface. This allows medical staff to not only be aware of changes in physiological parameter data but also to know the real-time values ​​of each physiological parameter. Displaying the remaining infusion time and infusion alarm indicators simultaneously facilitates medical staff in adjusting the necessary actions and workflows based on the infusion alarm indicators.

[0115] This embodiment provides a monitoring method that can be used in the aforementioned central station, wherein the parameter display area includes an infusion display area. Figure 7 This is a flowchart of a monitoring method according to an embodiment of the present invention, such as... Figure 7 As shown, the process includes the following steps:

[0116] S31, acquire physiological parameter data and infusion data of at least one target object at the same time.

[0117] Please see details Figure 3 S11 of the illustrated embodiment will not be described again here.

[0118] S32 displays physiological parameter data and infusion data in the corresponding parameter display area of ​​the monitoring main interface to perform joint analysis of changes in the vital signs of the target subject.

[0119] Please see details Figure 5S22 of the illustrated embodiment will not be described again here.

[0120] S33, in response to the selection operation of the infusion display area, displays the drug statistical analysis interface.

[0121] The drug statistical analysis interface includes a drug display area and a physiological parameter display area.

[0122] When medical staff need to view the correlation between infusion drug data and physiological parameter data, they can select the infusion display area. Correspondingly, the central station displays the drug statistical analysis interface in response to this selection. This interface displays statistical data on infused drugs and physiological parameter data. Specifically, it correlates infused drugs with physiological parameters over time. For example, if the target patient starts receiving drug A at 8:00 AM, the drug display area of ​​the statistical analysis interface can show the infusion rate or cumulative infusion volume of drug A starting at 8:00 AM, while the physiological parameter display area shows physiological parameter data starting at 8:00 AM.

[0123] Figure 8 An optional embodiment of the drug statistical analysis interface 301 is shown, which includes a drug display area 303 and a physiological parameter display area 304. The drug display area 303 and the physiological parameter display area 304 display analysis curves of the infused drugs and physiological parameters. The horizontal axis of these analysis curves is the time axis, reflecting the trend of the viewed content over time, and the vertical axis represents the parameter values ​​at the corresponding time points. Scroll bars 305 and 306 are used to scroll along the vertical axis, allowing medical personnel to drag and view data from later times and trend analysis graphs for more parameters. For example, medical personnel can drag the horizontal scroll bar 306 to view data from later or earlier times, and drag the vertical scroll bar 305 to view trend analysis graphs for different drugs or different physiological parameters.

[0124] S34, in response to the selection operation of physiological parameter data and infusion data, determines the infusion data of the target drug and the target physiological parameter data.

[0125] The drug statistical analysis interface also includes a target selection area. For example, Figure 8 The target selection area 302 shown provides parameter selection labels, drug selection labels, and drug curve labels. Based on this, the above-mentioned S34 includes:

[0126] S341, in response to the selection operation of the parameter selection label in the target selection area, displays the parameter selection interface.

[0127] As mentioned above, physiological parameter monitoring equipment monitors many types of physiological parameters, and different target subjects may require different physiological parameters to be monitored, while medical staff are concerned with different physiological parameters. Therefore, the central station provides parameter selection labels so that medical staff can select the appropriate physiological parameters for different monitoring needs.

[0128] When it is necessary to select physiological parameters, medical staff select the parameter selection tab in the target selection area. The central station responds to this selection operation by displaying the parameter selection interface. This interface provides a variety of physiological parameters for medical staff to choose from.

[0129] S342, in response to the selection operation of physiological parameters in the parameter selection interface, determines the target physiological parameter.

[0130] For example, Figure 9 An alternative implementation of the parameter selection interface is shown, which provides a variety of physiological parameters, allowing medical staff to select one or more as needed. The central station identifies the physiological parameter selected by the medical staff as the target physiological parameter, which is displayed in the physiological parameter display area of ​​the pharmacological statistical analysis interface.

[0131] In some optional embodiments of this example, the parameter selection interface includes a parameter list and a parameter group list, wherein each entry in the parameter group list includes at least two physiological parameters. Accordingly, S342 above may include: determining a target physiological parameter in response to a selection operation on the parameter list or parameter group list.

[0132] like Figure 9 As shown, the parameter selection interface provides both a parameter list and a parameter group list for medical staff to choose from. The difference between the parameter list and the parameter group list is that selecting from the parameter list requires multiple selections, while selecting from the parameter group list allows for the selection of at least two physiological parameters in a single step.

[0133] like Figure 9 As shown, the parameter selection interface 401 includes a parameter list 402 and a parameter group list 403. If it is necessary to select the six basic parameters, namely heart rate, respiration, blood pressure, blood oxygen, pulse rate, and body temperature, multiple operations are required if the selection is made in the parameter list 402; however, if the selection is made in the parameter group list 403, only the parameter group of the six basic parameters needs to be selected.

[0134] A list of parameter groups is provided, and by selecting items from the list, at least two physiological parameters can be determined at once, reducing the number of times the parameter list needs to be selected and improving monitoring efficiency.

[0135] As an optional implementation of this embodiment, S342 may further include:

[0136] In response to the operation of creating a parameter set for the target physiological parameters, a target parameter set is created.

[0137] For example, if healthcare professionals need to monitor multiple parameters simultaneously to address a specific nursing need, they can select these parameters from the parameter list and then create a target parameter group, thus organizing these parameters as a single entity. Subsequent selections will only require choosing this target parameter group to simultaneously select the corresponding parameters.

[0138] It provides adaptive creation of target parameter groups, which can combine physiological parameters according to the needs of medical staff, making it easier to select parameters later.

[0139] For example, when medical staff select the parameter selection tab, the central station displays parameter selection interface 401. Within parameter selection interface 401, 402 is the parameter list, allowing medical staff to select the physiological parameters to view based on actual clinical needs. After the medical staff selects the target physiological parameter and closes parameter selection interface 401, the waveform of the selected target physiological parameter is displayed in physiological parameter display area 304 of the drug statistical analysis interface. Within parameter selection interface 401, 403 is the parameter group list. Medical staff can click the "Create Parameter Group" button to create a parameter group using the currently selected physiological parameters, and then edit and delete the created parameter groups in parameter group list 403. If the medical staff selects a parameter group from the parameter group list and closes parameter selection interface 401, physiological parameter display area 304 displays the waveform of the corresponding target physiological parameter under the selected parameter group. This display is merely an example and is not limited to these parameters and drugs.

[0140] S343, Based on physiological parameter data and target physiological parameters, determine the target physiological parameter data.

[0141] After determining the target physiological parameters, the central station extracts the target physiological parameter data from the acquired physiological parameter data.

[0142] The system provides parameter selection labels to allow medical staff to set different physiological parameters for different target subjects, thus enabling personalized settings for each target subject.

[0143] S344, in response to the selection operation of the drug selection label in the target selection area, displays the drug selection interface.

[0144] As mentioned above, the infusion system monitors many types of infusion drugs, and different target subjects may require different infusion drugs, while healthcare professionals may have different concerns regarding the infusion drugs they need. Therefore, the central station provides drug selection labels to allow healthcare professionals to select the appropriate drugs for different monitoring needs.

[0145] When it is necessary to select an infusion drug, medical staff select the drug selection tab in the target selection area. The central station responds to this selection by displaying the drug selection interface. This interface provides a variety of drugs for medical staff to choose from.

[0146] S345, in response to the drug selection operation in the drug selection interface, determines the target drug.

[0147] For example, Figure 10 An alternative implementation of a drug selection interface 501 is shown, which provides a variety of drugs, allowing healthcare professionals to select one or more as needed. The central station identifies the drug selected by the healthcare professional as the target drug, which is displayed in the drug display area of ​​the drug statistical analysis interface.

[0148] S346, Based on infusion data and the target drug, determine the infusion data for the target drug.

[0149] After identifying the target drug, the central station matches it with the infusion data to determine the infusion data for that target drug.

[0150] By personalizing the selection of target drugs for different target groups, different target drugs can be configured for different target groups, making it easier for medical staff to monitor them.

[0151] In some optional implementations of this embodiment, S346 may include:

[0152] (1) In response to the selection operation of the drug curve label in the target selection area, the drug curve selection interface is displayed.

[0153] (2) In response to the selection operation of drug attributes in the drug curve selection interface, the drug attributes of the target drug are determined, including infusion rate and infusion cumulative amount.

[0154] (3) Determine the infusion data of the target drug based on the infusion data, the target drug and the drug properties of the target drug.

[0155] like Figure 11As shown, when medical staff need to select statistical information about a drug, they select the "Drug Curve" tab. Correspondingly, the central station displays the drug curve selection interface 601, where medical staff can make selections, such as selecting the infusion rate. Consequently, the drug display area of ​​the drug statistical analysis interface displays the curve showing the infusion rate of the target drug changing over time.

[0156] Alternatively, you can select both the infusion rate and the cumulative infusion volume. Correspondingly, the drug display area in the drug statistics analysis interface will simultaneously show the changes in the target drug's infusion rate and cumulative infusion volume over time.

[0157] S35 displays the infusion data of the target drug in the drug display area and the target physiological parameter data in the physiological parameter display area.

[0158] Specifically, the medication selection label allows healthcare professionals to easily set the types of infusion medications they need to view, such as... Figure 10 As shown in the diagram. 501 is the drug selection interface, where healthcare professionals can select the types of drugs they wish to view. 502 is the drug type list, which healthcare professionals can scroll through. Healthcare professionals should be able to select multiple drugs, select a single drug, and select all drugs. Selected drugs will be marked with a checkmark (e.g., a "√"), and different background colors will indicate the status of the healthcare professional's operation. If the healthcare professional selects a drug type and closes the 501 drug selection interface, the drug display area 303 will show the waveform corresponding to the selected drug.

[0159] Drug curve labels allow healthcare professionals to easily set the types of drug curves they need to view, primarily including infusion rate curves and cumulative infusion volumes, such as... Figure 11 As shown. 601 is the drug curve interface, where medical staff can set the curve type to view for a drug. 602 is the curve type list, where medical staff can select one or all curves. Selected curves are marked with a selection symbol (e.g., a "√" symbol), and different background colors indicate the status of the medical staff's operation. If the medical staff selects to display both the infusion rate curve and the cumulative infusion volume curve simultaneously and closes the drug curve interface 601, the drug display area 303 will show the two curve presentation formats for a specific drug, such as... Figure 11 The effect shown.

[0160] S36: After receiving the operation object for joint analysis, adjust the settings of the infusion data and display the adjusted infusion data in the parameter display area.

[0161] Please see details Figure 3 S13 of the illustrated embodiment will not be described again here.

[0162] The monitoring method provided in this embodiment performs statistical analysis on drug infusion data and target physiological parameter data in the drug statistical analysis interface, which makes it easier for medical staff to understand the impact of infused drugs on the vital signs of the target subject. Subsequently, the dosage and rate of drug can be adjusted by the changes in vital signs caused by changes in infused drugs, which can be used to assist clinical precision nursing. The operation is simple and the amount of information presented is large.

[0163] Although embodiments of the invention have been described in conjunction with the accompanying drawings, those skilled in the art can make various modifications and variations without departing from the spirit and scope of the invention, and such modifications and variations all fall within the scope defined by the appended claims.

Claims

1. A method of monitoring, characterized by, The method comprises: acquiring physiological parameter data and infusion data of at least one target object at the same time; displaying the physiological parameter data and the infusion data in corresponding parameter display areas in a monitoring main interface to jointly analyze vital sign changes of the target object, the monitoring main interface comprising a plurality of the parameter display areas, each of the parameter display areas corresponding to each of the target objects, and the parameter display areas comprising an infusion display area; in response to a selection operation on the infusion display area, displaying a drug statistical analysis interface, the drug statistical analysis interface comprising a drug display area and a physiological parameter display area; in response to a selection operation on the physiological parameter data and the infusion data, determining target drug infusion data and target physiological parameter data; displaying the target drug infusion data in the drug display area and the target physiological parameter data in the physiological parameter display area; receiving an adjustment setting on the infusion data after a joint analysis by an operation object, and displaying the infusion data after the adjustment setting in the parameter display area; wherein the drug statistical analysis interface further comprises a target selection area, and the response to the selection operation on the physiological parameter data and the infusion data to determine the target drug infusion data and the target physiological parameter data comprises: in response to a selection operation on a drug selection tab in the target selection area, displaying a drug selection interface; in response to a selection operation on a drug in the drug selection interface, determining the target drug; based on the infusion data and the target drug, determining the target drug infusion data.

2. The method of claim 1, wherein, The monitoring main interface further comprises a waveform display area, each of the waveform display areas corresponding to each of the parameter display areas, and the method further comprises: displaying a waveform of the physiological parameter data in the waveform display area.

3. The method according to claim 1 or 2, characterized in that, The infusion data comprises infusion remaining time and infusion alarm identification, the parameter display area comprises a remaining time display area and an alarm display area, and the displaying of the physiological parameter data and the infusion data in the corresponding parameter display areas in the monitoring main interface comprises: displaying the infusion remaining time in the remaining time display area of the corresponding parameter display area and displaying the infusion alarm identification in the alarm display area of the corresponding parameter display area, the infusion alarm identification corresponding to the infusion remaining time.

4. The method of claim 1, wherein, The response to the selection operation on the physiological parameter data and the infusion data to determine the target drug infusion data and the target physiological parameter data comprises: in response to a selection operation on a parameter selection tab in the target selection area, displaying a parameter selection interface; in response to a selection operation on a physiological parameter in the parameter selection interface, determining the target physiological parameter; based on the physiological parameter data and the target physiological parameter, determining the target physiological parameter data.

5. The method of claim 4, wherein, The parameter selection interface comprises a parameter list and a parameter group list, each entry in the parameter group list comprising at least two physiological parameters, and the response to the selection operation on the physiological parameter in the parameter selection interface to determine the target physiological parameter comprises: In response to a selection operation on the parameter list or the parameter group list, the target physiological parameter is determined.

6. The method of claim 4, wherein, In response to a selection operation on a physiological parameter in the parameter selection interface, the target physiological parameter is determined, and the method further includes: In response to a parameter group creation operation on the target physiological parameter, a target parameter group is created.

7. The method of claim 1, wherein, The infusion data of the target drug is determined based on the infusion data and the target drug, and the method further includes: In response to a selection operation on a drug curve label in the target selection area, a drug curve selection interface is displayed. In response to a selection operation on a drug attribute in the drug curve selection interface, a drug attribute of the target drug is determined, and the drug attribute includes an infusion rate and an infusion cumulative amount. The infusion data of the target drug is determined based on the infusion data, the target drug, and the drug attribute of the target drug.

8. A central station, characterized by The method includes: A display interface, a memory, and a processor, which are in communication connection with each other, the memory stores computer instructions, and the processor executes the computer instructions to perform the monitoring method of any one of claims 1-7.

9. A central monitoring system, characterized by The method includes: An infusion system for acquiring infusion data of a target object; A physiological parameter monitoring device for acquiring physiological parameter data of the target object; The central station of claim 8 is in communication connection with the infusion system and the physiological parameter monitoring device.

Images